文献速递关节外科创伤骨科

阿司匹林与全关节置换术后静脉血栓栓塞的预防:常见问题解答

Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions.
PubMed 文献 · Bone Joint J · 2017-01-01

该综述总结了阿司匹林用于关节置换术后静脉血栓栓塞(VTE)预防的现有证据,指出在无VTE重大风险因素(如既往VTE)的患者中,阿司匹林是有效、廉价且安全的预防方式,并解答了关于其使用的常见问题。

要点

  • 在无VTE重大风险因素的患者中,阿司匹林是关节置换术后预防VTE的有效、廉价且安全的方式。
  • 阿司匹林耐受性好且无需常规血液检测,较少导致血肿和持续性伤口渗液。
  • 选择预防药物需权衡减少VTE与降低出血风险,最佳方案和最佳药物尚不明确。

核心结论

  • 综合考虑所有因素,有令人信服的证据表明,在无VTE重大风险因素(如既往VTE)的患者中,阿司匹林是关节置换术后预防VTE的有效、廉价且安全的方式。

研究设计与样本

  • 综述,旨在总结阿司匹林用于关节置换术后VTE预防疗效的现有证据,并解答关于其使用的常见问题。

主要发现

  • 许多研究表明阿司匹林在减少关节置换术后VTE方面有效。
  • 阿司匹林价格低廉、耐受性良好,且使用无需常规血液检测。
  • 阿司匹林是较温和的药物,不太可能导致血肿形成,而血肿可能增加感染风险和再次手术需求。
  • 阿司匹林不太可能导致持续性伤口渗液,而持续性伤口渗液已被证明与低分子肝素(LMWH)等更激进药物的使用相关。
  • 尽管可使用多种药物,但其疗效和出血风险存在差异,最佳方案和最佳药物尚不明确。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The number of arthroplasties being performed increases each year. Patients undergoing an arthroplasty are at risk of venous thromboembolism (VTE) and appropriate prophylaxis has been recommended. However, the optimal protocol and the best agent to minimise VTE under these circumstances are not known. Although many agents may be used, there is a difference in their efficacy and the risk of bleeding. Thus, the selection of a particular agent relies on the balance between the desire to minimise VTE and the attempt to reduce the risk of bleeding, with its undesirable, and occasionally fatal, consequences. Acetylsalicylic acid (aspirin) is an agent for VTE prophylaxis following arthroplasty. Many studies have shown its efficacy in minimising VTE under these circumstances. It is inexpensive and well-tolerated, and its use does not require routine blood tests. It is also a 'milder' agent and unlikely to result in haematoma formation, which may increase both the risk of infection and the need for further surgery. Aspirin is also unlikely to result in persistent wound drainage, which has been shown to be associated with the use of agents such as low-molecular-weight heparin (LMWH) and other more aggressive agents. The main objective of this review was to summarise the current evidence relating to the efficacy of aspirin as a VTE prophylaxis following arthroplasty, and to address some of the common questions about its use. There is convincing evidence that, taking all factors into account, aspirin is an effective, inexpensive, and safe form of VTE following arthroplasty in patients without a major risk factor for VTE, such as previous VTE. Cite this article: Bone Joint J 2017;99-B:1420-30.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Azboy I, Barrack R, Thomas AM, et al. Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions. Bone Joint J. 2017. PMID: 29092979. doi:10.1302/0301-620X.99B11.BJJ-2017-0337.R2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。